DM
BSTC

Deerfield Management’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Deerfield Management’s Portfolio BSTC Stock Details BSTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-168,883
Closed -$5.96M – 139
2014
Q3 		$5.96M Hold
168,883
– – 0.22% 85
2014
Q2 		$4.55M Buy
+168,883
New +$4.4M 0.18% 90

Other funds holding BSTC

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TC
TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Deerfield Management's BSTC Position: Q4 2014 in Review

Deerfield Management sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2014, closing a stake of 168,883 shares — an estimated $5.96M sold.

Deerfield Management first reported a position in BSTC in Q2 2014 and held it in 2 quarters. The position peaked at $5.96M in Q3 2014. 85 funds tracked by Wall St. Rank hold BSTC as of Q4 2014.

  • Deerfield Management reported no remaining BioSpecifics Technologies Corp. position as of Q4 2014 after selling out during the quarter.
  • Deerfield Management sold 168,883 BioSpecifics Technologies Corp. shares in Q4 2014, an estimated $5.96M.
  • Deerfield Management first reported a position in BioSpecifics Technologies Corp. in Q2 2014 and held it in 2 quarters.
  • Deerfield Management's BioSpecifics Technologies Corp. position peaked at $5.96M in Q3 2014.
  • 85 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2014.

Based on Deerfield Management's 13F filing for Q4 2014, filed 17 Feb 2015.